BIOTECHNOLOGIJOS INST has a total of 16 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Lithuania, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are UNIV LATROBE, BUCHARDT OLE and MACINA ROBERTO A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Lithuania | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Sugars | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Medical preparations | |
#7 | Therapeutic chemical compounds | |
#8 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Matuliene Jurgita | 6 |
#2 | Matulis Daumantas | 6 |
#3 | Klimasauskas Saulius | 5 |
#4 | Liutkeviciute Zita | 5 |
#5 | Kriukiene Edita | 4 |
#6 | Zvirbliene Aurelija | 4 |
#7 | Sasnauskas Kestutis | 3 |
#8 | Ulrich Rainer | 3 |
#9 | Gedvilaite Alma | 3 |
#10 | Dudutiene Virginija | 3 |
Publication | Filing date | Title |
---|---|---|
LT2009023A | Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases | |
LT2008035A | 5-aryl-4-(5-substituted 2,4-dihydroxyfenil)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone and the intermediates for production thereof | |
LT2006066A | Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof | |
LT2005043A | Process for preparing monoclonal antibodies; hybridoma cell lines generated by this process and recombinant chimeric virus-like particles with inserted foreign protein fragments as immunogenes to generate hybridomas by this process | |
LT4947B | Alfa interferon pharmaceutical composition |